Technical Account Manager, Sino Biological US Inc.
BIOGRAPHY
Speaker
Event Date & Time
Date: November 10, 2022
Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET)
Abstract
Single B cell screening is a powerful and efficient strategy for generating antigen-specific monoclonal antibodies. Distinguished with fluorescence-activated B cell sorting, the Beacon® platform is based on plasma cell screening, making it easier to obtain antibody genes.
The Beacon® single-cell optofluidic system combines a unique optoelectro positioning (OEP) technology with novel microfluidic technology. It can be used to accurately select single cells on a chip, perform multiple single-cell assays, and export target cells based on specific results. The Beacon® optofluidic platform preserves the diversity of B cells, generating high-quality positive hits at an early stage of discovery and avoiding the loss of “good clones”.
The webinar will cover the following sections: 1. B cell differentiation and development; 2. Mainstream antibody screening platforms; 3. Beacon® platform; 4. Case studies using the Beacon® platform for antibody screening.
Learning Objectives
- Outline the mechanisms, pros and cons of different antibody screening platforms
- Illustrate the technical route of Beacon® single B cell antibody discovery
- Discuss the applications of Beacon® single B cell screening platform
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...